Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9K Sell
131
-34
-21% -$4.59K ﹤0.01% 901
2026
Q1
$23.5K Buy
165
+110
+200% +$17.4K ﹤0.01% 763
2025
Q4
$9.58K Sell
55
-24
-30% -$4.46K ﹤0.01% 800
2025
Q3
$16K Buy
79
+27
+52% +$5.5K ﹤0.01% 736
2025
Q2
$8.96K Sell
52
-20
-28% -$3.22K ﹤0.01% 817
2025
Q1
$11.2K Buy
72
+20
+38% +$3.44K ﹤0.01% 774
2024
Q4
$9.56K Buy
52
+40
+333% +$7.58K ﹤0.01% 796
2024
Q3
$2.17K Buy
12
+1
+9% +$176 ﹤0.01% 967
2024
Q2
$2K Buy
11
+6
+120% +$1.07K ﹤0.01% 962
2024
Q1
$945 Hold
5
– – ﹤0.01% 1005
2023
Q4
$875 Buy
+5
New +$767 ﹤0.01% 994
2023
Q3
– Sell
-5
Closed -$712 – 771
2023
Q2
$712 Hold
5
– – ﹤0.01% 965
2023
Q1
$641 Sell
5
-20
-80% -$2.54K ﹤0.01% 929
2022
Q4
$3K Buy
+25
New +$2.99K ﹤0.01% 789

Other funds holding PTC

CVA Family Office's PTC Position: Q2 2026 in Review

CVA Family Office reduced its PTC (PTC) stake by 21% in Q2 2026, selling an estimated $4.59K and leaving 131 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

CVA Family Office first reported a position in PTC in Q4 2022 and has held it in 14 quarters since. The position peaked at $23.5K in Q1 2026. 685 funds tracked by Wall St. Rank hold PTC as of Q2 2026.

  • CVA Family Office held 131 shares of PTC worth $14.9K as of Q2 2026.
  • CVA Family Office sold 34 PTC shares in Q2 2026, an estimated $4.59K.
  • PTC made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #901 holding.
  • CVA Family Office first reported a position in PTC in Q4 2022 and has held it in 14 quarters since.
  • CVA Family Office's PTC position peaked at $23.5K in Q1 2026.
  • 685 funds tracked by Wall St. Rank held PTC as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.